Sana'a - Saba:
A Yemeni research team from the Faculty of Pharmacy at Sana'a University received the certificate of Best Scientific Research for the year 2025 from the international journal EJPMR for their study on "Compatibility of Rivaroxaban-Excipients for the Development of Advanced Drug Delivery Systems".
The team consisted of Professor Mahmoud Al-Buryhi (Team Leader) and Drs. Mohammed Hamidaddin, Maged Alwan, Abdalwali Saif, Tawfeek Al-Obaidi, and Mokhtar Al-Ghorafi. The research has surpassed other research from around the world.
Prof. Al-Buryhi explained that the research aims to ensure the quality, efficacy, and stability of rivaroxaban. This anticoagulant contributes to the development of the pharmaceutical industry and the achievement of advanced pharmaceutical care.
He also congratulated Sana'a University on this scientific achievement and praised Yemen's scientific capabilities and the availability of natural resources used in the pharmaceutical industry.
It is worth noting that the European Journal of Medical Sciences chose the 2024 research by Professor Al-Buraihi and Professor Amina Al-Shaibani on "Seaweed-Derived Cancer Treatment" as the best scientific research for the past year, highlighting Yemen's achievements in the pharmaceutical and pharmaceutical field.

more of (Local) |